Abd-B/Hox9-Hox13

Total Page:16

File Type:pdf, Size:1020Kb

Abd-B/Hox9-Hox13 Index A ATF1, 218, 238, 240 Abd-B, see Abdominal-B ATF2, 218–219 (Abd-B/Hox9-Hox13) family ATF4, 219 Abdominal-A (Abd-A), 101, 104, 106 ATPase nucleosome remodelling Abdominal-B (Abd-B/Hox9-Hox13) family, complexes, 225 101, 104–107 Autoimmunity (role of Nuclear Abf1, 30, 41, 232, 235, 238, 240 Receptors), 142 Ace1, 41, 237 Auxin response factors (ARFs), 33, 47, 50, 52 Acetylation (of histone tails), 136, 225–227, Azfh, 112 237, 264, 269–270, 288 Activating function (AF) domains, 265 B Affymetrix microarrays, 183 Bacillus subtilis, 11, 13 Afhx, 112 Bacterial one-hybrid (B1H), 89, 157, 160, 163, AFT, 30, 39, 232 165, 169 Alfin-like, 41 BAF45A/B, 230 All-trans retinoic acid, 126, 129, 133 BAF53A/B, 230 Alpha-globin, 285 BAF57, 270 Alx, 109 BAF60A/C, 230, 270 Amoeba, 48 BAF250, 270 Androgen receptor (AR), 128, 137, 183 BarH, 103 Androstane, 126, 133 Barx, 108 Anemonia sp, 125 Basic, 26, 29–33, 39, 44–45, 77, 89, 116, ANT-C complex, 103 193–195, 223, 244 Antennapedia (antp), 96–98, 100, 102–108 Basic helix-loop-helix (bHLH), 26–27, 29–30, AP-1, 265, 270 32, 46, 48–50, 52–54, 268 AP-2/Basic helix-span-helix (bHSH), type of Basic leucine zipper (bZIP), 27, 29–33, 46–47, DNA-binding domain, 32 49–54, 268 AP2/GBD/EREBP/ERF/GCC-box binding BBR/BPC, 41, 50, 52 protein, 39 Bbx, 46 Apicomplexa, 30–31, 39, 48–49, 53 BEAF, 241 Apo-receptor, 130, 133 BEL class, 115 APSES, 30, 35, 49–50 BES1/BZR1/LAT61, 32 Arabidopsis thaliana, 48, 52, 100, 117 Beta-globin, 177, 285 ArcA, 12 Beta-scaffold, 26, 29, 44–47, 231–232, 238, Archaebacteria, 5 270–271 Argfx, 109 Bicoid (bcd), 37, 106 ARID/BRIGHT, 30, 35, 51 Bilaterian, 50–52, 54, 95 Arnt, 32, 51 Bisphenol A (BPA), 142 Arx, 109 BMI1, 239 T.R. Hughes (ed.), A Handbook of Transcription Factors, Subcellular Biochemistry 52, 297 DOI 10.1007/978-90-481-9069-0, C Springer Science+Business Media B.V. 2011 298 Index Box-A (putative TF binding site), Cholesterol, 126, 135, 139–140, 143 213–214, 217 Chromatin 53BP1, 264 chromatin context, 194 Brahma (BRM), 230 conformation capture (3C, 4C, 5C), 281 Brahma related gene 1 (BRG1), 230, 270 immunoprecipitation (ChIP), 79–80, BRG1/BRM associated factors (BAFs), 230 160–163, 169, 178–179, 181–187, 224, Brinker, 30, 36 231, 236, 239, 241–242, 280, 282, Bromodomain, 227–228, 264, 269–270 288–289 Bsx, 108 loop, 241 BTB/POZ, 77, 83–84, 87–88, 271 modifier (CM), 224–225, 228, B3/VP1/IAA/Auxin response factor (ARF), 33 230–231, 243 BX-C complex, 103 remodelers, 195, 197–198, 265 structure, 84, 162, 187, 194–197, 199, 205, C 224–228, 230, 236, 238, 241, 243–244, C2H2 zinc finger, 2, 26, 28–29, 31, 42, 46, 49, 261, 270, 279 51–52, 75–90, 215, 230, 263 Chromodomain, 238, 264 C2H2 zinc finger/beta-beta-alpha zinc Chromosomal territory, 283, 285–287, 291 finger/Krüppel, 42 Chromosome, 7, 13, 76, 84, 86, 103, 105, 110, C2HC/CCHC zinc finger, 42 128, 182–183, 185, 188, 208, 242–243, Caenorhabditis elegans, 52, 96 280–283, 286, 288–289, 291 Calcium-responsive transactivator CHX10, 109 (CREST), 230 Circadian cycle, 139 Candida glabrata, 232 9-cis retinoic acid, 127, 129 Cap maturation of mRNA, 267 CLASS genes, 103, 108, 110–112 CARM1, 270 Clock, 51, 139–141, 143 Cascades, 11–12, 17 Clr3, 238, 240 CASTing, 160 Clr4, 238, 240 Catabolite repression, 14, 16 C-Myc, 267, 270 Caudal (cad/Cdx), 107 Cnidarians (corals/sea anemones/jellyfish), 50 CBF, 46, 215 Coactivator, 132–135, 264, 270 CBF/NF-Y, 30, 40, 46 Code, recognition, 5, 89 CCAAT (TF binding site), 213–215, 217 COE/EBF, 41 Cdk9, 267 Co-factor, 79, 88–89, 112, 129, 135, 197, 285 CDP (CCAAT displacement protein), 111 Cognate Site Identifier (CSI), 165 C/EBP, 27, 32, 219, 235 Cohesin, 287–288 CEBPA, 185–186, 188 Cold shock domain (CSD), 33, 45 C/EBPβ, 270 Combinatorial (regulation), 15, 17–18, 268 Ceh-7, 100–101, 114 COMPASS (CMP) class, 111–112 Ceh-20, 113 Competition, 3, 10, 13, 157, 167–169, 177, Ceh-36, 99 193–194, 198–199, 201, 212, 219, 224 Cell cycle, yeast, 179 Competition (among TFs), 212 CENPB, 30, 36, 51 Competition assay, 167–169 CG-1/CAMTA, 33, 52 Constitutive androstane receptor (CAR), CHA1 promoter, 237 126, 137 ChIA-PET, 281–282 Context-specificity, 79, 84, 194 Chicken ovalbumin upstream promoter- Cooperativity (among TFs), 198 transcription factor (COUP-TF), Copper fist, 30, 41, 49–50 125, 127 Copy number variation (CNV), 86 Chicken β-globin locus, 241 Coregulators, 224–229, 231, 235, 242 ChIP-chip, 80, 162, 178–179, 181, Corepressor, 4, 132–134, 224, 236, 265, 184–185, 289 270–271 ChIP-seq, 80–82, 157, 160, 162–163, 165, 169, Co-repressor nuclear-receptor [CoRNR] 184–187, 280, 288 box, 132 Index 299 CpG dinucleotide, 182, 206–208 Dof, 30, 42, 47–48, 50 CpG island microarrays, 182 Domain accretion, 2 CpG islands, 182, 206–207, 212, 226 Dosage compensation, 289, 291 CREB, 32, 218–219, 231, 269 DP (dimerization partner for E2F proteins), 27, CREB binding protein (CBP), 231, 269 30, 36–37, 268 CRE (TF binding site), 3, 54, 156, 180, 217, Dprx, 109 224, 226, 233–234, 236 Drgx, 109 Cross-hybridization (on microarrays), 184 Drosophila, 46, 75, 80, 84, 96, 103–114, 117, CRP, 12–18, 21, 112 125–127, 130, 137, 140, 205–220, Cryptosporidium parvum, 49 238–239, 241, 244 CSL/LAG1/Suppressor of hairless, 33 Duplication and divergence, 2, 29, 49, 54, 109 CTCF, 80, 82, 234, 240–241 Dux, 109 CTD (RNA polymerase C-terminal Domain), 267 E Ctenophores (comb jellies), 50 E12, 32, 179, 218 Cut (gene), 102, 110–112 E2F, 27, 30, 36–37, 45, 49–51, 182–183, 220, CUT/ONECUT/CDP, 36 265–266, 268–270 CUT superclass, 110–111 E2F1, 183, 265–266, 270 CUX class, 111 E2F4, 27, 182 CxC/CRC/CPP-like, 41 E2F6, 269 CxxC, 30, 41 E75, 125–126, 129, 133, 135, 139–140 CycT1, 267 E-box (TF binding site), 219 Ecdysozoans, 137 D Ecdysteroids, 130, 134–135 DAL82, 40 Ecocyc, 11 DamID, 224, 282, 288 E. coli, 8, 10–19, 170, 194, 201, 282 DAX1, 128 EcR (Ecdysone Receptor), 130, 135 DBD database, 11 Effector domains, 4, 77, 83–84, 228, 263–265, DBD (DNA-binding domain), 1 267–272 2DBD-NR, 128 Egl–5, 104, 106 DBP/DNC, 40 EIN3/EIN3-like (EIL), 40 Dbx, 108 Electrophoresis, 156, 158, 161, 178 DCTCF, 241 Electrophoretic mobility shift assay (EMSA), DDT class, 115–116 156–160, 268, 281–282 De Bruijn sequence, 165 ELKF, 270 Defective proventriculus (dve), 99 Elongation (of transcription), 3, 261–262 Deformed (Dfd/Hox4) family, 106 Ems, 101–103, 108 Demosponges, 50–52 Emx, 101, 108 Deutrostome, 52 ENCODE, 185–187, 208, 242 Dictyostelium discoideum, 47 project, 185–186 Dimerization, 2, 29, 44, 50, 54, 84, 88, 114, Endocrine (Nuclear Receptors), 137–138, 142 130–132, 268 Endocrinology, 135, 137–138, 140–142 Dinucleotide frequencies (in promoters), Engrailed (en), 96–97, 108 206–208 Enhancer, 130, 235, 240–241, 244, 262, DIP-chip, 160 285–286 Diversifying selection, 2 Enhancer blocking, 241 Dll, 101, 103, 108 Epigenetics, 3, 243 Dlx, 108 Epitope tagging, 181 Dmbx, 109 ErbA-related (EAR), 127 DM/Doublesex, 42 Estrogen receptor (ER), 127, 129, 183, 230, DNA affinity matrix, 159 284–285 DNA microarrays, 164, 179, 183–185 Estrogen-related receptor (ERR), 127, 142 DNAse I, 177, 224, 280, 282 Esx, 109 300 Index Ets, 27, 30, 36–37, 45, 50–51, 208–209, 211, Gli family, 285 213–215, 217, 220 GLP, 269 ETS (TF binding site), 217 Glucocorticoid receptor (GR), 127, 137, 140, Eumetazoa, 50–51 142, 237, 265 Evi1, 42, 81 Grainyhead/CP2/LSF, 34 Evolution, 3, 5, 8, 16–18, 31, 47, 49–54, GRAS/Scarecrow, 40 75–90, 103, 106, 109–111, 125–130, Gsc, 109 134, 137–138, 140, 160, 185–186, 197, Gsx, 107–108 201, 212, 230 GTF2I-like, 32 Evx, 101, 103, 107 Guggulsterone, 135 Extradenticle, 113 E(z) (Enhancer of zeste) (PRC2 H component), 239 Hairy, 51 Hbp, 46 F HB-PHD / ZF-HD, 37 FAR1/FRS, 42 H/C link, 76–77 Farnesoid X receptor (FXR), 126, 130, 135, HD-ZIP classes, 115 137, 142 Heat Shock Factor (HSF), 37, 45, 49 FAX/FAD-KZNFs, 88 Helix-turn-helix, 11, 26, 29, 44–45, 97, 110, Feed Forward Loop (FFL), 16–17 116–117 FIS/Fis, 12, 14–15 Heme, 129, 135–137, 139–140 FISH (fluorescence in situ hybridization), “H” enhancer (of olfactory receptors), 286 281–282, 290 Hepatocyte nuclear factor-4 (HNF4), 125, 127, FNR, 12, 97 129, 166 Footprinting, 156–158 Hesx, 109 Forkhead (FKH)/Forkhead box (Fox), 37 Heterochromatin exclusion zones, 290 Formaldehyde-assisted isolation ofregulatory Heterokonts/stramenopiles, 49 elements (FAIRE), 224 Hexapeptide motif, 100, 103 Formaldehyde crosslinking, 177 HGRα (human Glucocorticoid Receptor Fos, 31–32, 218 alpha), 265–266, 268 FOXA1/HNF3A, 234 Hhex, 108 FOXA2, 185 Hi-C, 281–283, 290 Fractal globule, 281 High Mobility Group (HMG) proteins, 195 FRAP (fluorescence recovery after Histone acetyl transferases (HATs), 225–226 photobleaching), 225 Histone arginine methytransferases, 134, 270 Fushi tarazu (ftz), 96, 106 Histone code, 225 Histone deacetylases (HDACs), 85, 134, G 235–238, 240, 264–265, 270–271, 288 G9a, 269 Histone H1, 195, 197, 234 GAGA factor (GAF), 239 Histone methyltransferases (HMTs), 269–270 Gal4, 48, 179, 228–229, 233, 235 Histone modifications, 4–5, 195, 201, 224–225, GAL genes, 231 227–228, 231, 242, 264, 269, 280, 288 GATA, 31, 49, 125 Histone modifiers, 198, 225, 227–228, 238 GATA1, 285 Histones, 183, 194, 199, 224, 227, 234, 236, GATA4, 230 239, 264, 269 GBF zinc finger (Dicty-ostelium), 42 H3K27me, 226, 239, 241, 243, 269, 287–289 G/C content, 197 H3K27me3, see H3K27 trimethylation GCM, 43, 47 (H3K27me3) Gcn5, 228, 265 H3K27 trimethylation (H3K27me3), 226, GCR1, 40 238–239, 241, 269, 288–289 Germ cell nuclear factor (GCNF), 125, 128 H3K4me, 226, 288 Giardia lamblia, 47, 49 H3K9me, see H3K9 methylation (H3K9me) Glaucophyta (simple glaucophyte algae), 46 H3K9 methylation
Recommended publications
  • Methylation of the Homeobox Gene, HOPX, Is Frequently Detected in Poorly Differentiated Colorectal Cancer
    ANTICANCER RESEARCH 31: 2889-2892 (2011) Methylation of the Homeobox Gene, HOPX, Is Frequently Detected in Poorly Differentiated Colorectal Cancer YOSHIKUNI HARADA, KAZUHIRO KIJIMA, KAZUKI SHINMURA, MAKIKO SAKATA, KAZUMA SAKURABA, KAZUAKI YOKOMIZO, YOUHEI KITAMURA, ATSUSHI SHIRAHATA, TETSUHIRO GOTO, HIROKI MIZUKAMI, MITSUO SAITO, GAKU KIGAWA, HIROSHI NEMOTO and KENJI HIBI Gastroenterological Surgery, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan Abstract. Background: Homeodomein only protein x pathogenesis of colorectal cancer (4-8). It is also known that (HOPX) gene methylation has frequently been detected in gene promoter hypermethylation is involved in the cancer tissues. The methylation status of the HOPX gene in development and progression of cancer (9). An investigation colorectal cancer was examined and compared to the of genetic changes is important in order to clarify the clinocopathological findings. Materials and Methods: tumorigenic pathway of colorectal cancer (10). Eighty-nine tumor samples and corresponding normal tissues The homeodomain only protein x (HOPX) gene, also were obtained from colorectal cancer patients who known as NECC1 (not expressed in choriocarcinoma clone underwent surgery at our hospital. The methylation status of 1), LAGY (lung cancer-associated gene Y), and OB1 (odd the HOPX gene in these samples was examined by homeobox 1 protein), was initially identified as an essential quantitative methylation-specific PCR (qMSP). Subsequently, gene for the modulation of cardiac growth and development the clinicopathological findings were correlated with the (11). Three spliced transcript variants, HOPX-α, HOPX-β methylation status of the HOPX gene. Results: HOPX gene and HOPX-γ, encode the same protein, which contains a methylation was found in 46 (52%) out of the 89 colorectal putative homeodomain motif that acts as an adapter protein carcinomas, suggesting that it was frequently observed in to mediate transcriptional repression (12).
    [Show full text]
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia
    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
    [Show full text]
  • G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress
    G2 Phase Cell Cycle Regulation by E2F4 Following Genotoxic Stress by MEREDITH ELLEN CROSBY Submitted in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Thesis Advisor: Dr. Alex Almasan Department of Environmental Health Sciences CASE WESTERN RESERVE UNIVERSITY May, 2006 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approve the dissertation of ______________________________________________________ candidate for the Ph.D. degree *. (signed)_______________________________________________ (chair of the committee) ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ ________________________________________________ (date) _______________________ *We also certify that written approval has been obtained for any proprietary material contained therein. TABLE OF CONTENTS TABLE OF CONTENTS………………………………………………………………….1 LIST OF FIGURES……………………………………………………………………….5 LIST OF TABLES………………………………………………………………………...7 ACKNOWLEDGEMENTS……………………………………………………………….8 LIST OF ABBREVIATIONS……………………………………………………………10 ABSTRACT……………………………………………………………………………...15 CHAPTER 1. INTRODUCTION 1.1. CELL CYCLE REGULATION: HISTORICAL OVERVIEW………………...17 1.2. THE E2F FAMILY OF TRANSCRIPTION FACTORS……………………….22 1.3. E2F AND CELL CYCLE CONTROL 1.3.1. G0/G1 Phase Transition………………………………………………….28 1.3.2. S Phase…………………………………………………………………...28 1.3.3. G2/M Phase Transition…………………………………………………..30 1.4.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • A Genome-Wide Analysis of the ERF Gene Family in Sorghum
    A genome-wide analysis of the ERF gene family in sorghum H.W. Yan, L. Hong, Y.Q. Zhou, H.Y. Jiang, S.W. Zhu, J. Fan and B.J. Cheng Key Laboratory of Crop Biology of Anhui Province, Anhui Agricultural University, Hefei, China Corresponding author: B.J. Cheng E-mail: [email protected] Genet. Mol. Res. 12 (2): 2038-2055 (2013) Received November 9, 2012 Accepted March 8, 2013 Published May 13, 2013 DOI http://dx.doi.org/10.4238/2013.May.13.1 ABSTRACT. The ethylene response factor (ERF) family are members of the APETALA2 (AP2)/ERF transcription factor superfamily; they are known to play an important role in plant adaptation to biotic and abiotic stress. ERF genes have been studied in Arabidopsis, rice, grape, and maize; however, there are few reports of ERF genes in sorghum. We identified 105 sorghum ERF (SbERF) genes, which were categorized into 12 groups (A-1 to A-6 and B-1 to B-6) based on their sequence similarity, and this new method of classification for ERF genes was then further characterized. A comprehensive bioinformatic analysis of SbERF genes was performed using a sorghum genomic database, to analyze the phylogeny of SbERF genes, identify other conserved motifs apart from the AP2/ERF domain, map SbERF genes to the 10 sorghum chromosomes, and determine the tissue-specific expression patterns of SbERF genes. Gene clustering indicates that SbERF genes were generated by tandem duplications. Comparison of SbERF genes with maize ERF homologs suggests lateral gene transfer between monocot species. These results can contribute to our understanting of Genetics and Molecular Research 12 (2): 2038-2055 (2013) ©FUNPEC-RP www.funpecrp.com.br Analysis of the ERF gene family in sorghum 2039 the evolution of the ERF gene family.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Identification of BBX Proteins As Rate-Limiting Co-Factors of HY5
    1 Identification of BBX proteins as rate-limiting co-factors of HY5. 2 Katharina Bursch1, Gabriela Toledo-Ortiz2, Marie Pireyre3, Miriam Lohr1, Cordula Braatz1, Henrik 3 Johansson1* 4 1. Institute of Biology/Applied Genetics, Dahlem Centre of Plant Sciences (DCPS), Freie Universität 5 Berlin, Albrecht-Thaer-Weg 6. D-14195 Berlin, Germany. 6 2. Lancaster Environment Centre, Lancaster University, Lancaster LA1 4YQ, UK 7 3. Department of Botany and Plant Biology, Section of Biology, Faculty of Sciences, University of 8 Geneva, 30 Quai E. Ansermet, 1211 Geneva 4, Switzerland 9 *E-mail [email protected] 10 Abstract 11 As a source of both energy and environmental information, monitoring the incoming light is crucial for 12 plants to optimize growth throughout development1. Concordantly, the light signalling pathways in 13 plants are highly integrated with numerous other regulatory pathways2,3. One of these signal 14 integrators is the bZIP transcription factor HY5 which holds a key role as a positive regulator of light 15 signalling in plants4,5. Although HY5 is thought to act as a DNA-binding transcriptional regulator6,7, the 16 lack of any apparent transactivation domain8 makes it unclear how HY5 is able to accomplish its many 17 functions. Here, we describe the identification of three B-box containing proteins (BBX20, 21 and 22) 18 as essential partners for HY5 dependent modulation of hypocotyl elongation, anthocyanin 19 accumulation and transcriptional regulation. The bbx202122 triple mutant mimics the phenotypes of 20 hy5 in the light and its ability to suppress the cop1 mutant phenotype in darkness. Furthermore, 84% 21 of genes that exhibit differential expression in bbx202122 are also HY5 regulated, and we provide 22 evidence that HY5 requires the B-box proteins for transcriptional regulation.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Epigenetics Page 1
    Epigenetics esiRNA ID Gene Name Gene Description Ensembl ID HU-13237-1 ACTL6A actin-like 6A ENSG00000136518 HU-13925-1 ACTL6B actin-like 6B ENSG00000077080 HU-14457-1 ACTR1A ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) ENSG00000138107 HU-10579-1 ACTR2 ARP2 actin-related protein 2 homolog (yeast) ENSG00000138071 HU-10837-1 ACTR3 ARP3 actin-related protein 3 homolog (yeast) ENSG00000115091 HU-09776-1 ACTR5 ARP5 actin-related protein 5 homolog (yeast) ENSG00000101442 HU-00773-1 ACTR6 ARP6 actin-related protein 6 homolog (yeast) ENSG00000075089 HU-07176-1 ACTR8 ARP8 actin-related protein 8 homolog (yeast) ENSG00000113812 HU-09411-1 AHCTF1 AT hook containing transcription factor 1 ENSG00000153207 HU-15150-1 AIRE autoimmune regulator ENSG00000160224 HU-12332-1 AKAP1 A kinase (PRKA) anchor protein 1 ENSG00000121057 HU-04065-1 ALG13 asparagine-linked glycosylation 13 homolog (S. cerevisiae) ENSG00000101901 HU-13552-1 ALKBH1 alkB, alkylation repair homolog 1 (E. coli) ENSG00000100601 HU-06662-1 ARID1A AT rich interactive domain 1A (SWI-like) ENSG00000117713 HU-12790-1 ARID1B AT rich interactive domain 1B (SWI1-like) ENSG00000049618 HU-09415-1 ARID2 AT rich interactive domain 2 (ARID, RFX-like) ENSG00000189079 HU-03890-1 ARID3A AT rich interactive domain 3A (BRIGHT-like) ENSG00000116017 HU-14677-1 ARID3B AT rich interactive domain 3B (BRIGHT-like) ENSG00000179361 HU-14203-1 ARID3C AT rich interactive domain 3C (BRIGHT-like) ENSG00000205143 HU-09104-1 ARID4A AT rich interactive domain 4A (RBP1-like) ENSG00000032219 HU-12512-1 ARID4B AT rich interactive domain 4B (RBP1-like) ENSG00000054267 HU-12520-1 ARID5A AT rich interactive domain 5A (MRF1-like) ENSG00000196843 HU-06595-1 ARID5B AT rich interactive domain 5B (MRF1-like) ENSG00000150347 HU-00556-1 ASF1A ASF1 anti-silencing function 1 homolog A (S.
    [Show full text]
  • HMGB1 in Health and Disease R
    Donald and Barbara Zucker School of Medicine Journal Articles Academic Works 2014 HMGB1 in health and disease R. Kang R. C. Chen Q. H. Zhang W. Hou S. Wu See next page for additional authors Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles Part of the Emergency Medicine Commons Recommended Citation Kang R, Chen R, Zhang Q, Hou W, Wu S, Fan X, Yan Z, Sun X, Wang H, Tang D, . HMGB1 in health and disease. 2014 Jan 01; 40():Article 533 [ p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/533. Free full text article. This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. Authors R. Kang, R. C. Chen, Q. H. Zhang, W. Hou, S. Wu, X. G. Fan, Z. W. Yan, X. F. Sun, H. C. Wang, D. L. Tang, and +8 additional authors This article is available at Donald and Barbara Zucker School of Medicine Academic Works: https://academicworks.medicine.hofstra.edu/articles/533 NIH Public Access Author Manuscript Mol Aspects Med. Author manuscript; available in PMC 2015 December 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Mol Aspects Med. 2014 December ; 0: 1–116. doi:10.1016/j.mam.2014.05.001. HMGB1 in Health and Disease Rui Kang1,*, Ruochan Chen1, Qiuhong Zhang1, Wen Hou1, Sha Wu1, Lizhi Cao2, Jin Huang3, Yan Yu2, Xue-gong Fan4, Zhengwen Yan1,5, Xiaofang Sun6, Haichao Wang7, Qingde Wang1, Allan Tsung1, Timothy R.
    [Show full text]
  • Investigation of the Underlying Hub Genes and Molexular Pathogensis in Gastric Cancer by Integrated Bioinformatic Analyses
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Investigation of the underlying hub genes and molexular pathogensis in gastric cancer by integrated bioinformatic analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.20.423656; this version posted December 22, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract The high mortality rate of gastric cancer (GC) is in part due to the absence of initial disclosure of its biomarkers. The recognition of important genes associated in GC is therefore recommended to advance clinical prognosis, diagnosis and and treatment outcomes. The current investigation used the microarray dataset GSE113255 RNA seq data from the Gene Expression Omnibus database to diagnose differentially expressed genes (DEGs). Pathway and gene ontology enrichment analyses were performed, and a proteinprotein interaction network, modules, target genes - miRNA regulatory network and target genes - TF regulatory network were constructed and analyzed. Finally, validation of hub genes was performed. The 1008 DEGs identified consisted of 505 up regulated genes and 503 down regulated genes.
    [Show full text]